Integrated treatment regime for duchenne muscular dystrophy

Abstract

Duchenne muscular dystrophy (DMD), a genetic neuromuscular disorder, has a pernicious influence on skeletal and cardiac muscle tissue and results in a significant decline in the life span of those affected. The destruction is mainly attributed to perpetuating inflammation and fibrosis. This review explores the potential of a comprehensive therapeutic approach with an objective to minimize ongoing damage and reconstitute normal tissue.